annual CFO:
-$347.25M-$198.05M(-132.75%)Summary
- As of today (June 28, 2025), BEAM annual cash flow from operations is -$347.25 million, with the most recent change of -$198.05 million (-132.75%) on December 31, 2024.
- During the last 3 years, BEAM annual CFO has fallen by -$280.98 million (-424.00%).
- BEAM annual CFO is now -1641.47% below its all-time high of $22.53 million, reached on December 31, 2022.
Performance
BEAM Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$103.88M-$27.52M(-36.04%)Summary
- As of today (June 28, 2025), BEAM quarterly cash flow from operations is -$103.88 million, with the most recent change of -$27.52 million (-36.04%) on March 31, 2025.
- Over the past year, BEAM quarterly CFO has dropped by -$4.14 million (-4.15%).
- BEAM quarterly CFO is now -147.55% below its all-time high of $218.49 million, reached on March 31, 2022.
Performance
BEAM quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$351.38M-$4.14M(-1.19%)Summary
- As of today (June 28, 2025), BEAM TTM cash flow from operations is -$351.38 million, with the most recent change of -$4.14 million (-1.19%) on March 31, 2025.
- Over the past year, BEAM TTM CFO has dropped by -$212.26 million (-152.56%).
- BEAM TTM CFO is now -284.16% below its all-time high of $190.80 million, reached on March 31, 2022.
Performance
BEAM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BEAM Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -132.8% | -4.2% | -152.6% |
3 y3 years | -424.0% | -147.6% | -284.2% |
5 y5 years | -382.3% | -279.2% | -377.8% |
BEAM Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1641.5% | at low | -147.6% | +5.4% | -284.2% | +0.6% |
5 y | 5-year | -1641.5% | at low | -147.6% | +5.4% | -284.2% | +0.6% |
alltime | all time | -1641.5% | at low | -147.6% | +5.4% | -284.2% | +0.6% |
BEAM Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$103.88M(+36.0%) | -$351.38M(+1.2%) |
Dec 2024 | -$347.25M(+132.7%) | -$76.36M(-13.3%) | -$347.25M(+155.7%) |
Sep 2024 | - | -$88.13M(+6.2%) | -$135.81M(-1.2%) |
Jun 2024 | - | -$83.01M(-16.8%) | -$137.47M(-1.2%) |
Mar 2024 | - | -$99.75M(-173.8%) | -$139.13M(-6.7%) |
Dec 2023 | -$149.19M(-762.3%) | $135.07M(-250.4%) | -$149.19M(-57.8%) |
Sep 2023 | - | -$89.78M(+6.0%) | -$353.46M(+4.5%) |
Jun 2023 | - | -$84.67M(-22.9%) | -$338.17M(+10.6%) |
Mar 2023 | - | -$109.81M(+58.7%) | -$305.78M(-1457.4%) |
Dec 2022 | $22.53M(-134.0%) | -$69.19M(-7.1%) | $22.53M(-75.9%) |
Sep 2022 | - | -$74.50M(+42.5%) | $93.55M(-45.3%) |
Jun 2022 | - | -$52.28M(-123.9%) | $171.05M(-10.4%) |
Mar 2022 | - | $218.49M(>+9900.0%) | $190.80M(-387.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$66.27M(-30.8%) | $1.83M(-39.1%) | -$66.27M(-28.3%) |
Sep 2021 | - | $3.01M(-109.2%) | -$92.40M(-20.8%) |
Jun 2021 | - | -$32.53M(-15.7%) | -$116.62M(+9.1%) |
Mar 2021 | - | -$38.58M(+58.8%) | -$106.93M(+11.7%) |
Dec 2020 | -$95.74M(+33.0%) | -$24.30M(+14.5%) | -$95.74M(+7.3%) |
Sep 2020 | - | -$21.21M(-7.1%) | -$89.24M(+5.0%) |
Jun 2020 | - | -$22.84M(-16.6%) | -$85.02M(+15.6%) |
Mar 2020 | - | -$27.39M(+53.9%) | -$73.54M(+2.1%) |
Dec 2019 | -$72.00M(+254.7%) | -$17.80M(+4.8%) | -$72.00M(+32.8%) |
Sep 2019 | - | -$16.99M(+49.7%) | -$54.20M(+45.7%) |
Jun 2019 | - | -$11.35M(-56.1%) | -$37.21M(+43.9%) |
Mar 2019 | - | -$25.86M | -$25.86M |
Dec 2018 | -$20.30M | - | - |
FAQ
- What is Beam Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Beam Therapeutics?
- What is Beam Therapeutics annual CFO year-on-year change?
- What is Beam Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Beam Therapeutics?
- What is Beam Therapeutics quarterly CFO year-on-year change?
- What is Beam Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Beam Therapeutics?
- What is Beam Therapeutics TTM CFO year-on-year change?
What is Beam Therapeutics annual cash flow from operations?
The current annual CFO of BEAM is -$347.25M
What is the all time high annual CFO for Beam Therapeutics?
Beam Therapeutics all-time high annual cash flow from operations is $22.53M
What is Beam Therapeutics annual CFO year-on-year change?
Over the past year, BEAM annual cash flow from operations has changed by -$198.05M (-132.75%)
What is Beam Therapeutics quarterly cash flow from operations?
The current quarterly CFO of BEAM is -$103.88M
What is the all time high quarterly CFO for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash flow from operations is $218.49M
What is Beam Therapeutics quarterly CFO year-on-year change?
Over the past year, BEAM quarterly cash flow from operations has changed by -$4.14M (-4.15%)
What is Beam Therapeutics TTM cash flow from operations?
The current TTM CFO of BEAM is -$351.38M
What is the all time high TTM CFO for Beam Therapeutics?
Beam Therapeutics all-time high TTM cash flow from operations is $190.80M
What is Beam Therapeutics TTM CFO year-on-year change?
Over the past year, BEAM TTM cash flow from operations has changed by -$212.26M (-152.56%)